Randomised clinical study of the consistency of three lots of SB Biologicals' dTpa vaccine in terms of immunogenicity and reactogenicity, and of the immunogenicity and reactogenicity of SB Biologicals' pa vaccine and Lederle's Td vaccine when administered as a booster dose to healthy adolescents at the age of 10 to 14 years

Trial Profile

Randomised clinical study of the consistency of three lots of SB Biologicals' dTpa vaccine in terms of immunogenicity and reactogenicity, and of the immunogenicity and reactogenicity of SB Biologicals' pa vaccine and Lederle's Td vaccine when administered as a booster dose to healthy adolescents at the age of 10 to 14 years

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Nov 2006

At a glance

  • Drugs Diphtheria-tetanus vaccine; DTaP vaccine; Pertussis acellular vaccine
  • Indications Diphtheria; Pertussis; Tetanus
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 03 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top